BALA CYNWYD, Pa.
, Nov. 21, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of directors of Innotrac Corporation ("Innotrac" or the "Company") (Nasdaq- INOC) relating to the proposed acquisition of the Company by an affiliate of Sterling Partners ("Sterling").
Click here to learn more about the investigation
, or call 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Innotrac shareholders will receive only
in cash for each share of Innotrac stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Innotrac for not acting in the Company's shareholders' best interests in connection with the sale process. In addition, the investigation seeks to determine if conflicts of interest played a role in the transaction. Following the completion of the transaction Innotrac's CEO and other members of management will continue in their management of the Company and will retain a significant equity position in Innotrac.
If you own shares of Innotrac common stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact
Jason L. Brodsky, Esquire
Evan J. Smith, Esquire
at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602,
Bala Cynwyd, PA
19004, by e-mail at
, by visiting
, by visiting
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.